The influence of leptin on some clinical and biochemical parameters in patients with essential hypertension with or without the metabolic syndrome;Wpływ leptyny na wybrane wskaźniki kliniczne i biochemiczne u chorych na samoistne nadciśnienie tȩtnicze z zespołem metabolicznym i bez tego zespołu

Nadcisnienie Tetnicze

Volumn 10, Issue 4, 2006, Pages 251-258

  Gural, Jadwiga ^b   Widecka, Justyna ^b   Widecka, Katarzyna ^b   Widecka, Krystyna ^a,c  

^a Klinika Endokrynologii   (Poland)

^b Indywidualna Specjalistyczna Praktyka Lekarska ^*  (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Arterial Hypertension; Leptin; Metabolic syndrome

Indexed keywords

ALDOSTERONE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; RENIN; SODIUM; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; WAIST CIRCUMFERENCE;

EID: 33750402441     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adamczak H., Wiȩcek A., Kokot F. Czy leptyna uczestniczy w patogenezie nadciśnienia tȩtniczego? Nadciśnienie Tȩtnicze 1999; 1: 52-58.
2. Agata J., Masuda A., Takada M. i wsp. High plasma immunoreactive leptin levels in essential hypertension. Am. J. Hypertens. 1997; 10: 1171-1174.
3. Dutkiewicz-Rakowska M., Wocial B., Ignatowska-Świtalska H. i wsp. Czy istnieje współzależność miȩdzy stȩżeniem leptyny, układem współczulnym i masa̧ lewej komory serca u chorych z nadciśnieniem tȩtniczym pierwotnym w zależności od płci i wskaźnika masy ciała? Nadciśnienie Tȩtnicze 2002; 2: 91-97.
4. Masuo K., Mikami H., Ogihara T. i wsp. Symphatetic hyperactivity and hyperinsulinemia are realated with hyperleptynemia and hypertension in a Japanese population. J. Hypertens. 1998; 16 (2): 157-160.
5. Suter P.M., Locher R., Häsler E. i wsp. Is there a role for ob gene product leptin in essential hypertension? Am. J. Hypertens. 1998; 11: 1305-1311.
6. Haynes W.G., Morgan D.A., Djalali A. i wsp. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33 (2): 542-547.
7. Haynes W.G., Morgan D.A., Walsh S.A. i wsp. Sympathetic activation to leptin is mediated by the hypothalamus. Hypertension 1997; 30 (3 Pt. 2): 619-623.
8. Jackson E.K., Li P. Human leptin has natriuretic activity in the rat. Am. J. Physiol. 1997; 272 (F): 333-338.
9. Serradeil-Le Gal C., Raufarte D., Brassard G. i wsp. Characterization and location of lepin receptors in the rat. Fed. Eur. Biochem. Soc. Lett. 1977; 404: 185-191.
10. Bouloumie A., Drexler H.C.A., Lafontan M. i wsp. Leptin, the product of ob gene, promotes angiogenesis. Circ. Res. 1998; 83: 1059-1066.
11. Considine R.V., Caro J.F. Pleiotropic cellular effects of leptin. Curr. Opin. Endocrinol. Diabetes. 1999; 6: 163-169.
12. Oda A., Taniguchi T., Takahashi A. i wsp. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Artheriosclerosis 1997; 134: 1-2.
13. Sader S., Nian M., Liu P. Leptin: a novel link between obesity, diabetes, cardiovascular risk and ventricular hypertrophy. Circulation 2003; 108: 644-646.
14. Zasady postȩpowania w nadciśnieniu tȩtniczym. Stanowisko Polskiego Towarzystwa Nadciśnienia Tȩtniczego. Nadciśnienie Tȩtnicze 2003; 7 (supl. A).
15. Swales J.D. Overview of essential hypertension. W: Swales J.D. i wsp. (red.) Textbook of Hypertension. Blackwell Scientific, Oxford 1994: 655-660.
16. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Export Panel an Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
17. Aizawa-Abe M., Ogawa Y., Masazaki H. i wsp. Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 2000; 105: 1243-1252.
18. Masuo K., Mikami H., Ogihara T. i wsp. Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135-1140.
19. Mrozikiewicz-Rakowska B., Pupek-Musialik D. Czy leptyna i noradrenalina uczestnicza̧ w kształtowaniu nadciśnienia tȩtniczego u otyłych osób? Nadciśnienie Tȩtnicze 2000; 4 (2): 89-96.
20. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
21. Reaven G.M., Lithell H., Lendberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 1996; 334: 374-381.
22. Tuominen J.A., Ebeling P., Laquier F.W. i wsp. Serum leptin concentration and fuel homeostasis in healthy man. Eur. J. Clin. Invest. 1997; 27: 206-211.
23. Mizuno A., Murakami T., Otani S. i wsp. Leptin affects pancreatic endocrine function through the sympathetic nervous system. Endocrinology 1998; 139: 3863-3870.
24. Kieffer T.J., Heller R.S., Habener J.F. Leptin receptors expressed on pancreatic β cells. Bioch. Biophys. Res. Comm. 1996; 224: 522-527.
25. Kolaczynski J.W., Nyce R.M., Considine R.V. i wsp. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
26. Leyva F., Godsland I.F., Ghatei M. i wsp. Hyperleptynemia as component of a metabolic syndrome of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 928-933.
27. Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism 1995; 9: 15-17.
28. Hall J.E. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-394.
29. Landsberg L. Diet, obesity and hypertension. A hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q. J. Med. 1986; 236: 1081-1090.
30. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insuline affects blood pressure, and why). J. Hypertens. 2001; 19: 523-528.
31. Scherrer U., Sartori C. Insulin as vascular and sympathoexcitary hormone. Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
32. Tuk M.L. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19 (I): 67-177.
33. Narkiewicz K., Kato M., Philips B.G. i wsp. Leptin interacts with heart rate but not symphatetic nerve traffic in healthy mole subjects. J. Hypertens. 2001; 19: 1089-1094.
34. Narkiewicz K., Somers V.K., Mos L. i wsp. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J. Hypertens. 1999; 17: 245-249.
35. Shorr U., Blanschke K., Turan S. i wsp. Relationship between angiotensinogen, leptin and blood pressure levels in young normatensive men. J. Hypertens. 1998; 16: 1475-1480.
36. Kaplan N.M. Nadciśnienie tȩtnicze. Wyd. I. Witkowska M. (red.). Wydawnictwo Medyczne Urban & Partner. Wrocław 1999: 49-52.
37. Dunbar J.C., Hu J., Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46: 2040-2043.
38. Haynes W.G., Morgan D.A., Walsh S.A. i wsp. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 1997; 100: 270-278.
39. Shek E.W., Brands M.W., Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31 (2): 409-414.
40. Grassi G., Servalle G., Cattaneo B.M. i wsp. Sympathetic activation in obese normatensive subjets. Hypertension 1995; 25: 560-563.